CVE-2022-42117

MEDIUMCVSS 6.1/10EPSS 0.50%

Last modified

CVE-2022-42117 is a medium-severity vulnerability rated 6.1/10 on the CVSS scale. A Cross-site scripting (XSS) vulnerability in the Frontend Taglib module in Liferay Portal 7.3.2 through 7.4.3.16, and Liferay DXP 7.3 before update 6, and 7.4 before update 17 allows remote attackers to inject arbitrary web script or HTML.. EPSS estimates a 0.50% chance of exploitation in the next 30 days.

Description

A Cross-site scripting (XSS) vulnerability in the Frontend Taglib module in Liferay Portal 7.3.2 through 7.4.3.16, and Liferay DXP 7.3 before update 6, and 7.4 before update 17 allows remote attackers to inject arbitrary web script or HTML.

Metrics

CVSS 3.1
6.1/10

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

EPSS Probability
0.50%

39.0th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

VendorProductVersionsUpdate
LiferayDxp< 7.3
LiferayDxp7.3
LiferayDxp7.4Ga1
LiferayLiferay Portal>= 7.3.2, <= 7.4.3.16

References

Timeline

Published
Last Modified
Status
Modified

Frequently Asked Questions

What is CVE-2022-42117?
A Cross-site scripting (XSS) vulnerability in the Frontend Taglib module in Liferay Portal 7.3.2 through 7.4.3.16, and Liferay DXP 7.3 before update 6, and 7.4 before update 17 allows remote attackers to inject arbitrary web script or HTML.
How severe is CVE-2022-42117?
CVE-2022-42117 has a CVSS score of 6.1/10 (MEDIUM severity). The EPSS model estimates a 0.50% probability of exploitation in the next 30 days.
How do I fix CVE-2022-42117?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2022-42117?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST